Metabolic Biomarkers In Midtrimester Maternal Plasma Can Accurately Predict Adverse Pregnancy Outcome in Patients with SLE

Patients with systemic lupus erythematosus (SLE) are at increased risk for adverse pregnancy outcome (APO). Accurate prediction of APO is critical to identify, counsel, and manage these high-risk patients. We undertook this study to identify novel biomarkers in mid-trimester maternal plasma to ident...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Seung Mi, Lee, Eun Mi, Park, Jin Kyun, Jeon, Hae Sun, Oh, Sohee, Hong, Subeen, Jung, Young Mi, Kim, Byoung Jae, Kim, Sun Min, Norwitz, Errol R., Lee, Eun Bong, Louangsenlath, Souphaphone, Park, Chan-Wook, Jun, Jong Kwan, Park, Joong Shin, Lee, Do Yup
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6811572/
https://www.ncbi.nlm.nih.gov/pubmed/31645572
http://dx.doi.org/10.1038/s41598-019-51285-8

Ejemplares similares

Ejemplares similares